The use of CRISPR for variant specificity in the genetic diagnosis of primary immunodeficiency disease (PID)
Keyword(s):
ABSTRACTThe functional validation of genetic variants of uncertain significance (VUS) found in PID patients by next-generation sequencing has traditionally been carried out in model systems that are susceptible to artefact. We use CRISPR correction of primary human T lymphocytes to demonstrate that a specific variant in an IL-6R deficient patient is causative for their condition. This methodology can be adapted and used for variant assessment of the heterogeneous genetic defects that affect T lymphocytes in PID.
1973 ◽
Vol 52
(4)
◽
pp. 919-928
◽
2019 ◽
pp. 54-64
2020 ◽
Vol 79
(Suppl 1)
◽
pp. 66.2-66